Showing results (51-60 of 150) with videos related to
Sort By:
Pageof 15
The Clinical Journal of Pain|April 12, 2022
Evaluation of Analgesic Efficacy and Opioid-sparing Effect of Duloxetine After Arthroscopic Rotator Cuff Repair: A Randomized Clinical TrialPeng Su, Long Pang, Shu Li, et al.ACS Applied Materials & Interfaces|April 2, 2010
Ultraviolet photodetector based on a MgZnO film grown by radio-frequency magnetron sputteringYanmin Zhao, Jiying Zhang, Dayong Jiang, et al.RSC Advances|June 13, 2022
The extract from the roots of Rose odorata sweet var. gigantean (Coll. et Hemsl.) Rehd. et Wils attenuates DSS-induced ulcerative colitis by regulating the Nrf2/NF-κB signaling pathwaysXinyu Li, Rui Liu, Yanmin Zhao, et al.Annals of Hematology|June 19, 2017
Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemiaYanmin Zhao, Jiasheng Wang, Yi Luo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive DonorsYibo Wu, Jimin Shi, Yamin Tan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2020
Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell TransplantationYanmin Zhao, Jimin Shi, Yi Luo, et al.British Journal of Haematology|June 16, 2025
Upadacitinib, a selective JAK1 inhibitor, for the treatment of steroid refractory chronic graft-versus-host disease: A multicentre real-world studyLiting Niu, Minli Hu, Yi Xia, et al.Molecular Medicine Reports|June 18, 2016
NR2F2 regulates bone marrow-derived mesenchymal stem cell-promoted proliferation of Reh cellsNi Zhu, Huafang Wang, Jieping Wei, et al.Hematology (Amsterdam, Netherlands)|January 9, 2025
Blinatumomab added to conditioning regimen of allogeneic hematopoietic stem cell transplantation for adult MRD-positive acute lymphoblastic leukemia: a single-center case seriesHui Fu, Yanmin Zhao, Huarui Fu, et al.Bone Marrow Transplantation|October 20, 2020
Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysisLuxin Yang, Yamin Tan, Jimin Shi, et al.Pageof 15